Neoleukin Therapeutics (NLTX) Stock
NLTX is no longer traded. Neoleukin Therapeutics was delisted from the Nasdaq in December 2023.
Prices on this page are historical; the last trade was December 19, 2023 at $15.10.
Neoleukin Therapeutics stock price history
NLTX final trading statistics
- Final close
- $15.10
- Final trading day
- Dec 19, 2023
- Market cap at delisting
- $8.20M
- Shares outstanding
- 2.35M
- Final 52-week range
- $0.41 – $15.49
- Avg. volume (final 3 mo.)
- 33,932
- All-time high (split-adj.)
- $442.60 · Aug 2015
- All-time low (split-adj.)
- $3.34 · Dec 2023
- Return since IPO
- -86.1%
- Beta
- 1.10
- Book value / share
- $34.18
- Price / book
- 0.44
Neoleukin Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$56.0M | -$1.04 |
| FY2021 | $6.0K | -$58.4M | -$1.10 |
| FY2020 | $451.0K | -$25.0M | -$0.81 |
| FY2019 | $0.00 | -$69.4M | -$0.84 |
| FY2018 | $25.00M | -$31.6M | -$1.35 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Neoleukin Therapeutics
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Neoleukin Therapeutics stock FAQ
What happened to Neoleukin Therapeutics stock?
Neoleukin Therapeutics stock was delisted from the Nasdaq. Its final close was $15.10 on December 19, 2023.
Is NLTX stock still trading?
No. NLTX was delisted from the Nasdaq in December 2023 and no longer trades on a U.S. exchange.
What was the last price of NLTX stock?
NLTX closed at $15.10 on its final trading day, December 19, 2023, for a market value of about $8.20M.
What were Neoleukin Therapeutics's revenue and earnings in its last full fiscal year?
Neoleukin Therapeutics reported revenue of $0.00 and net income of -$56.0M in fiscal 2022, its last full year as a public company.
When did Neoleukin Therapeutics go public?
Neoleukin Therapeutics stock began trading on March 7, 2014.